PT - JOURNAL ARTICLE AU - Vernooij-Dassen, Myrra AU - Verspoor, Eline AU - Samtani, Suraj AU - Sachdev, Perminder AU - Ikram, M. Arfan AU - Vernooij, Meike W. AU - Hubers, Claudia AU - Chattat, Rabih AU - Lenart, Marta AU - Rymaszewska, Joanna AU - Szczesnia, Dorota AU - Brodaty, Henry AU - Welmer, Anna-Karin AU - Maddock, Jane AU - van der Velpen, Isabelle AU - Wiegelmann, Henrik AU - Marseglia, Anna AU - Richards, Marcus AU - Melis, Rene AU - de Vugt, Marjolein AU - Moniz-Cook, Esme AU - Jeon, Yun-Hee AU - Perry, Marieke AU - Wolf-Ostermann, Karin TI - CONCEPTUAL ADVANCEMENT: SOCIAL HEALTH AS A FACILITATOR IN THE USE OF COGNITIVE RESERVE AID - 10.1101/2022.06.07.22276079 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.07.22276079 4099 - http://medrxiv.org/content/early/2022/06/07/2022.06.07.22276079.short 4100 - http://medrxiv.org/content/early/2022/06/07/2022.06.07.22276079.full AB - Dementia is a syndrome where the origins are not fully understood, and we have no cure. New thinking through exploration of paradigms beyond biological approaches has scope to improve knowledge about this complex condition. We aim to explore the role of social health in cognitive decline and the onset of dementia. We performed a scoping and a systematic review of the literature, hypothesizing that social health acts as a driver for stimulating the use of cognitive reserve. The review yielded theoretical pathways and evidence for the association between neurobiological and social health markers. However, lack of conceptual clarity on social health hinders its articulation and associated inclusion of social health markers in epidemiological studies. We therefore apply concept advancement of social health. We developed a conceptual framework, and we present a first testing of our overarching hypothesis. This framework proved to effectively guide the identification of social health markers in our epidemiological data bases. This promotes the identification of modifiable risk factors, which may in turn shape new avenues for preventive interventions.Competing Interest StatementNone declared by the authors, except for Perminder Sachdev and Henry Brodaty. Conflict of interest: PS is on the Expert Advisory Committee of Biogen Australia. Conflict of interest: HB has been an advisory board member or consultant to Nutricia Australia, Biogen, Roche Pharmaceuticals and Synapse2Neuron. Funding Statementthe paper is part of the SHARED project funded by JPND 733051082Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Review of published dataI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors